Evidence map›Paper›PMID 31059029›Full record

ArticleMolecular medicine reports2019

Prediction of IER5 structure and function using a bioinformatics approach.

Qiang Xiong, Xiaoyan Jiang, Xiaodan Liu, Pingkun Zhou, Kuke Ding

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qiang XiongNational Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing 100088, P.R. China.
Xiaoyan JiangNational Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing 100088, P.R. China.
Xiaodan LiuDepartment of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Pingkun ZhouDepartment of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China.
Kuke DingNational Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing 100088, P.R. China.
National Institute for Radiological Protection · CNBeijing Radiation Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immediate‑early response gene 5 (IER5) is a gene involved in the regulation of the cell cycle, and its structure and function have been investigated by bioinformatics analyses. The present study determined the sites of promoter methylation and gene ontology (GO) annotations associated with IER5. In addition, we conducted a prediction analysis to determine the physical and chemical properties, hydrophobicity/hydrophilicity, posttranslational modification, subcellular localization, transmembrane structure, signal peptide and secondary and tertiary structures of IER5. One CpG island and several methylated sites were identified close to the promoter of IER5. The GO analysis suggested that IER5 could bind ions and proteins that were mainly associated with metabolic processes. IER5 comprised 327 amino acids and was reported to be an unstable hydrophilic protein with an isoelectric point of 4.91. A total of 18 O‑glycosylation sites and 22 phosphorylation sites were identified within this protein. The subcellular localization of IER5 was mainly in the nucleus, and its main secondary structural element was the α‑helix. Bioinformatic analyses of the features of IER5 may improve understanding of its structure and function; however, experimental verification is required.

Indexed as

Computational BiologyAmino Acid SequenceCell CycleCpG IslandsDNA-Binding ProteinsGene OntologyHumansHydrophobic and Hydrophilic InteractionsImmediate-Early ProteinsNuclear ProteinsPromoter Regions, GeneticProtein ConformationProtein Processing, Post-TranslationalTranscription FactorsTranscription, GeneticDNA-Binding ProteinsIER5 protein, humanImmediate-Early ProteinsNuclear ProteinsTranscription Factors

Identifiers

PMID31059029
PMCPMC6522821
OpenAlexW2936205612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.